SCHEMBL19352897

SCHEMBL19352897

CCCCCC/C=C\CCCCCCCC(=O)N[C@H](CO)[C@@H](O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ASAH2 Q9NR71 1/20 0.58
▸ DEGS1 O15121 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ CETP P11597 4/20 0.55
▸ ALDH1A1 P00352 3/20 0.55
▸ THRB P10828 2/20 0.55
▸ LMNA P02545 2/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ CYP2C19 P33261 2/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ MARS2 Q96GW9 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ RPLP1 P05386 1/20 0.51
▸ RPLP0 P05388 1/20 0.51
▸ RPS17 P08708 1/20 0.51
▸ RPSA P08865 1/20 0.51
▸ RPS2 P15880 1/20 0.51
▸ RPL35A P18077 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19342491 1.00 ASAH2 (0.58) ASAH2DEGS1MAPTCETPALDH1A1
SCHEMBL19342489 1.00 ASAH2 (0.58) ASAH2DEGS1MAPTCETPALDH1A1
SCHEMBL19328599 1.00 ASAH2 (0.58) ASAH2DEGS1MAPTCETPALDH1A1
SCHEMBL19352747 0.99 ASAH2 (0.57) ASAH2DEGS1MAPTCETPALDH1A1
SCHEMBL19342488 0.99 ASAH2 (0.57) ASAH2DEGS1MAPTCETPALDH1A1
SCHEMBL19352898 0.98 ASAH2 (0.55) ASAH2DEGS1MAPTCETPALDH1A1
SCHEMBL19342490 0.98 ASAH2 (0.55) ASAH2DEGS1MAPTCETPALDH1A1
SCHEMBL13930315 0.94 ASAH2 (0.64) ASAH2DEGS1MAPTALDH1A1LMNA
SCHEMBL13930323 0.94 ASAH2 (0.64) ASAH2DEGS1MAPTALDH1A1LMNA
SCHEMBL4240806 0.94 ASAH2 (0.64) ASAH2DEGS1MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170260134-A1 Ceramide Analogs DEPARTMENT OF VETERAN AFFAIRS 2017-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170260134-A1 Ceramide Analogs SGMS1, CERT1, SGMS2 ASAH2 9/4885DEGS1 33/4885MAPT 1542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback